title: Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review.
authors.affiliation: Department of Hematology, West China Hospital, Sichuan University, Key Lab of Hematology of Sichuan Province, Chengdu, China; Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Chun
authors.initials: C
authors.lastname: Cao
authors.affiliation: Department of Hematology, West China Hospital, Sichuan University, Key Lab of Hematology of Sichuan Province, Chengdu, China.
authors.forename: Ting
authors.initials: T
authors.lastname: Liu
authors.affiliation: Department of Hematology, West China Hospital, Sichuan University, Key Lab of Hematology of Sichuan Province, Chengdu, China.
authors.forename: Huanling
authors.initials: H
authors.lastname: Zhu
authors.affiliation: Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Wang
authors.affiliation: Department of Hematology, West China Hospital, Sichuan University, Key Lab of Hematology of Sichuan Province, Chengdu, China.
authors.forename: Shen
authors.initials: S
authors.lastname: Kai
authors.affiliation: Department of Hematology, West China Hospital, Sichuan University, Key Lab of Hematology of Sichuan Province, Chengdu, China. Electronic address: hxmutangguo@gmail.com.
authors.forename: Bing
authors.initials: B
authors.lastname: Xiang
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004386:Duodenum / Q000473:pathology; D015251:Epirubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011719:Pyrazines / Q000008:administration & dosage; D012074:Remission Induction; D013270:Stomach / Q000473:pathology; D013792:Thalidomide / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D015251:Epirubicin; D013792:Thalidomide; D014750:Vincristine; D000069286:Bortezomib; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
keywords: Chemotherapy; Epstein-Barr virus-encoded small RNA-negative; Human immunodeficiency virus-negative; Interphase fluorescence in situ hybridization; Non-hodgkin lymphoma